Thursday, January 17, 2008

A poor quarter for Novartis


Swiss drugmaker Novartis has today reported a 45% drop in fourth-quarter net profit as a $444 million restructuring charge pressured earnings and sales at the pharmaceuticals unit were hit by generic competition and the Zelnorm withdrawal.

No comments: